US 12,433,993 B2
Systems and methods for fluid delivery
Dean Kamen, Bedford, NH (US); John M. Kerwin, Manchester, NH (US); Larry B. Gray, Merrimack, NH (US); Marc A. Mandro, Bow, NH (US); and David Blumberg, Jr., Deerfield, NH (US)
Assigned to DEKA Products Limited Partnership, Manchester, NH (US)
Filed by DEKA Products Limited Partnership, Manchester, NH (US)
Filed on Jul. 24, 2023, as Appl. No. 18/225,229.
Application 18/225,229 is a continuation of application No. 16/998,741, filed on Aug. 20, 2020, granted, now 11,707,567.
Application 16/998,741 is a continuation of application No. 15/871,571, filed on Jan. 15, 2018, granted, now 10,751,467, issued on Aug. 25, 2020.
Application 15/871,571 is a continuation of application No. 14/336,530, filed on Jul. 21, 2014, granted, now 9,867,930, issued on Jan. 16, 2018.
Application 14/336,530 is a continuation of application No. 12/560,106, filed on Sep. 15, 2009, granted, now 8,784,364, issued on Jul. 22, 2014.
Claims priority of provisional application 61/141,996, filed on Dec. 31, 2008.
Claims priority of provisional application 61/141,781, filed on Dec. 31, 2008.
Claims priority of provisional application 61/101,105, filed on Sep. 29, 2008.
Claims priority of provisional application 61/101,053, filed on Sep. 29, 2008.
Claims priority of provisional application 61/101,115, filed on Sep. 29, 2008.
Claims priority of provisional application 61/101,077, filed on Sep. 29, 2008.
Claims priority of provisional application 61/097,021, filed on Sep. 15, 2008.
Prior Publication US 2024/0042127 A1, Feb. 8, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/142 (2006.01); A61M 5/145 (2006.01); A61M 5/168 (2006.01); A61M 5/172 (2006.01); G01F 11/08 (2006.01); G05D 7/06 (2006.01); G08C 17/02 (2006.01); H04B 7/26 (2006.01)
CPC A61M 5/14244 (2013.01) [A61M 5/142 (2013.01); A61M 5/14224 (2013.01); A61M 5/14248 (2013.01); A61M 5/14586 (2013.01); A61M 5/16809 (2013.01); A61M 5/16886 (2013.01); A61M 5/172 (2013.01); A61M 5/1723 (2013.01); G01F 11/086 (2013.01); G05D 7/0647 (2013.01); G05D 7/0676 (2013.01); G08C 17/02 (2013.01); H04B 7/2609 (2013.01); A61M 2005/14268 (2013.01); A61M 2005/16863 (2013.01); A61M 2205/0266 (2013.01); A61M 2205/0294 (2013.01); A61M 2205/18 (2013.01); A61M 2205/332 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3375 (2013.01); A61M 2205/3546 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/50 (2013.01); A61M 2205/52 (2013.01); A61M 2205/8237 (2013.01); A61M 2206/22 (2013.01); A61M 2209/045 (2013.01); A61M 2230/201 (2013.01); Y10T 29/49236 (2015.01); Y10T 29/494 (2015.01); Y10T 29/49412 (2015.01); Y10T 29/49826 (2015.01); Y10T 29/49828 (2015.01)] 20 Claims
OG exemplary drawing
 
1. A method for at least partial closed-loop control of a medical condition, the method comprising:
providing a medical fluid infusion pump comprising an acoustic volume monitor for measuring the volume of medical fluid pumped to a patient by the medical fluid infusion pump;
providing at least a first continuous analyte monitor and a second continuous analyte monitor;
providing a controller in communication with the first and second continuous analyte monitors, the controller comprising a processor;
the first continuous analyte monitor and the second continuous analyte monitor sending electrical signals to the processor in the controller and the processor in the controller correlating the electrical signals to an analyte value, and
if an analyte value from the first continuous analyte monitor differs by greater than a predetermined threshold amount from an analyte value from the second continuous analyte monitor, then disregarding the analyte value from the first continuous analyte monitor and the analyte value from the second continuous analyte monitor.